CDC7
Cell division cycle 7-related protein kinase
As of the edition of 20 October 2026, CDC7 (cell division cycle 7-related protein kinase, UniProt O00311) has 3 drugs tested at it and 3 companies on the list, 3 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- O00311
- How well studied
- Chemical tools exist; no approved drug acts on it
- Where it sits in the cell
- Inside the cell
- Solved structures
- 9
- Disease areas
- Cancer; Digestive system; Hormones; Lungs and airways
- Registered trials of its drugs
- 6
Drugs at this target
| Status | Count |
|---|---|
| Went quiet | 1 |
| Stopped | 2 |
| Total | 3 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Simurosertib | Went quiet | Phase 2 | none listed |
| NMS-1116354 | Stopped | Phase 1 | none listed |
| BMS-863233 | Stopped | Phase 2 | none listed |
3 of 3 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route A | 3 |
| Total on the list | 3 |
| Company | Route |
|---|---|
| Bristol Myers Squibb | Route A |
| Takeda | Route A |
| Nerviano Medical Sciences | Route A |
The other 0 companies at CDC7
In the product3 companies in all; 0 are not named here, and no score is.
See the 3 companies at CDC7, ranked, with the facts behind eachRequest access. Nothing is shown until you do.